| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.1 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |